338 related articles for article (PubMed ID: 17981087)
21. Leukaemic stem cells: drug resistance, metastasis and therapeutic implications.
Wong RS; Cheong SK
Malays J Pathol; 2012 Dec; 34(2):77-88. PubMed ID: 23424769
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML.
Valent P; Sadovnik I; Eisenwort G; Bauer K; Herrmann H; Gleixner KV; Schulenburg A; Rabitsch W; Sperr WR; Wolf D
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470642
[TBL] [Abstract][Full Text] [Related]
23. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
[TBL] [Abstract][Full Text] [Related]
24. Eradication of leukemia stem cells as a new goal of therapy in leukemia.
Ravandi F; Estrov Z
Clin Cancer Res; 2006 Jan; 12(2):340-4. PubMed ID: 16428470
[TBL] [Abstract][Full Text] [Related]
25. Targeting the bone marrow microenvironment in acute leukemia.
Karantanou C; Godavarthy PS; Krause DS
Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
[TBL] [Abstract][Full Text] [Related]
26. Differential regulation of myeloid leukemias by the bone marrow microenvironment.
Krause DS; Fulzele K; Catic A; Sun CC; Dombkowski D; Hurley MP; Lezeau S; Attar E; Wu JY; Lin HY; Divieti-Pajevic P; Hasserjian RP; Schipani E; Van Etten RA; Scadden DT
Nat Med; 2013 Nov; 19(11):1513-7. PubMed ID: 24162813
[TBL] [Abstract][Full Text] [Related]
27. Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species.
Dou J; Li L; Guo M; Mei F; Zheng D; Xu H; Xue R; Bao X; Zhao F; Zhang Y
Int J Nanomedicine; 2021; 16():1231-1244. PubMed ID: 33633448
[TBL] [Abstract][Full Text] [Related]
28. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
Al-Mawali A; Gillis D; Lewis I
J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
[TBL] [Abstract][Full Text] [Related]
29. Leukemia stem cells: Old concepts and new perspectives.
Mariani SA; Calabretta B
Mol Aspects Med; 2014 Oct; 39():102-9. PubMed ID: 23820118
[TBL] [Abstract][Full Text] [Related]
30. Identifying leukemia stem cells--is it feasible and does it matter?
Lutz C; Hoang VT; Buss E; Ho AD
Cancer Lett; 2013 Sep; 338(1):10-4. PubMed ID: 22820159
[TBL] [Abstract][Full Text] [Related]
31. Extinguishing the Embers: Targeting AML Metabolism.
Culp-Hill R; D'Alessandro A; Pietras EM
Trends Mol Med; 2021 Apr; 27(4):332-344. PubMed ID: 33121874
[TBL] [Abstract][Full Text] [Related]
32. Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia.
Kikushige Y; Miyamoto T
Oncology; 2015; 89 Suppl 1():28-32. PubMed ID: 26551150
[TBL] [Abstract][Full Text] [Related]
33. Impact of Leukemia Stem Cells Phenotype Expression on Response to Induction Therapy in Acute Myeloid Leukemia Patients.
Almohsen F; Al-Mudallal SS
Cardiovasc Hematol Disord Drug Targets; 2020; 20(2):145-151. PubMed ID: 31438833
[TBL] [Abstract][Full Text] [Related]
34. Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells.
Cook AM; Li L; Ho Y; Lin A; Li L; Stein A; Forman S; Perrotti D; Jove R; Bhatia R
Blood; 2014 May; 123(18):2826-37. PubMed ID: 24668492
[TBL] [Abstract][Full Text] [Related]
35. Selective elimination of leukemia stem cells: hitting a moving target.
Crews LA; Jamieson CH
Cancer Lett; 2013 Sep; 338(1):15-22. PubMed ID: 22906415
[TBL] [Abstract][Full Text] [Related]
36. Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation.
Chomel JC; Bonnet ML; Sorel N; Sloma I; Bennaceur-Griscelli A; Rea D; Legros L; Marfaing-Koka A; Bourhis JH; Ame S; Guerci-Bresler A; Rousselot P; Turhan AG
Oncotarget; 2016 Jun; 7(23):35293-301. PubMed ID: 27167108
[TBL] [Abstract][Full Text] [Related]
37. Cell surface receptor-targeted therapy of acute myeloid leukemia: a review.
Frankel AE; Sievers EL; Scheinberg DA
Cancer Biother Radiopharm; 2000 Oct; 15(5):459-76. PubMed ID: 11155818
[TBL] [Abstract][Full Text] [Related]
38. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
[TBL] [Abstract][Full Text] [Related]
39. Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?
Bernasconi P; Farina M; Boni M; Dambruoso I; Calvello C
Am J Hematol; 2016 May; 91(5):507-17. PubMed ID: 26822317
[TBL] [Abstract][Full Text] [Related]
40. SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells.
Tahk S; Vick B; Hiller B; Schmitt S; Marcinek A; Perini ED; Leutbecher A; Augsberger C; Reischer A; Tast B; Humpe A; Jeremias I; Subklewe M; Fenn NC; Hopfner KP
J Hematol Oncol; 2021 Sep; 14(1):155. PubMed ID: 34579739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
